|
Vol 55(2021) N 6 p. 884-888; DOI 10.1134/S0026893321050058 S.B. Duan1,2, S.S. Wei1,2, H.M. Wang1,2, S.H. Ding1,2, Y.Z. Chen1,2, J.J. Tian1,2, Y.J. Wang1, W. Chen3, J. Chen3*, Q.L. Meng1** Intein-Mediated Protein trans-Splicing of the Recombinant Streptavidin on Magnetosomes 1Suzhou Institute of Biomedical Engineering and Technology, Suzhou, 215163 China2Jihua Laboratory, Foshan, 315200 China 3Suzhou Blood Center, Suzhou, 215006 China *108065767@qq.com **69161018@qq.com Received - 2020-11-18; Revised - 2021-02-22; Accepted - 2021-03-12 When expressing streptavidin recombinant polypeptide on magnetosomes (called bacterial magnetic nanoparticles, or BMPs), the presence of endogenous bacterial biotin might be detrimental. In the study, the streptavidin monomer fragment (S1-116) was fused with the intein N-terminal (termed precursor S1-116-IN), and S1-116-IN was expressed in E. coli (BL21). Meanwhile, the SA117-160 fragment was fused with the C-terminal intein, and then this chimeric polypeptide was expressed on magnetosomes by fusion with magnetosome membrance protein MamF. In the in vitro protein splicing system, the purified engineered magnetosomes (BMP-SA117-160-IC) and the S1-116-IN precursor were mixed. Intein-mediated trans-splicing reaction was induced to produce the functional magnetic beads BMP-SA. Our results indicate that intein-mediated protein trans-splicing may lead to efficient synthesis of the recombinant streptavidin on the magnetosomes, showing its promising potential to produce other functional magnetic nanoparticles. magnetosomes, functional magnetic nanoparticles, streptavidin, intein-mediated protein splicing |